Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

RMC-9805

Catalog No.
C8668
A covalent inhibitor of KRASG12D
Grouped product items
SizePriceStock Qty
10mM (in 1mL DMSO)
$786.00
Ship with 5-10 days
1mg
$150.00
Ship with 5-10 days
5mg
$386.00
Ship with 5-10 days
10mg
$612.00
Ship with 5-10 days
25mg
$1,013.00
Ship with 5-10 days
50mg
$1,620.00
Ship with 5-10 days
100mg
$2,610.00
Ship with 5-10 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

RMC-9805 (CAS 2922732-54-3) is a covalent inhibitor specifically targeting GTP-bound KRASG12D. It binds to the cellular chaperone cyclophilin A (CypA) to form a binary complex, which subsequently covalently modifies GTP-bound KRASG12D. This CypA-catalyzed reaction achieves greater than 95% modification of GTP-bound KRASG12D (second-order rate constant: 89.9 M⁻¹s⁻¹), while exhibiting negligible modification of KRASWT (<1%), KRASG12C (18%), and KRASG12E (9%). The resulting trimeric complex, comprising CypA, KRASG12D, and RMC-9805, disrupts the interaction between KRASG12D and downstream effectors such as CRAF, RALGDS, and PLCɛ, thereby inhibiting oncogenic RAS signaling.

References:

[1] Weller C, Burnett GL, Jiang L, Chakraborty S, Zhang D, Vita NA, Dilly J, Kim E, Maldonato B, Seamon K, Eilerts DF, Milin A, Marquez A, Spradlin J, Helland C, Gould A, Ziv TB, Dinh P, Steele SL, Wang Z, Mu Y, Chugh S, Feng H, Hennessey C, Wang J, Roth J, Rees M, Ronan M, Wolpin BM, Hahn WC, Holderfield M, Wang Z, Koltun ES, Singh M, Gill AL, Smith JAM, Aguirre AJ, Jiang J, Knox JE, Wildes D. A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors. Science. 2025 Jul 24;389(6758):eads0239. doi: 10.1126/science.ads0239. Epub 2025 Jul 24. PMID: 40705880.

Chemical Properties

StorageStore at -20°C
M.Wt1168.44
Cas No.2922732-54-3
FormulaC63H88F3N11O7
SynonymsZoldonrasib;KRAS G12D inhibitor 18
Chemical Name(2S)-2-cyclopentyl-2-((S)-7-((2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl)-2,7-diazaspiro[4.4]nonan-2-yl)-N-((22S,63S,4S)-12-(5-(4-cyclopropylpiperazin-1-yl)-2-((S)-1-methoxyethyl)pyridin-3-yl)-10,10-dimethyl-5,7-dioxo-11-(2,2,2-trifluoroethyl)-61,6
SDFDownload SDF
Canonical SMILESO=C(OCC(C)(C)CC1=[C@@]([C@@]2=C([C@H](C)OC)N=CC(N3CCN(C4CC4)CC3)=C2)N(CC(F)(F)F)C5=C1C=C6C=C5)[C@@H]7CCCN(C([C@H](C[C@H]8CN6CCO8)NC([C@H](C9CCCC9)N%10C[C@]%11(CN(C([C@H]%12[C@@H](C%13CC%13)N%12C)=O)CC%11)CC%10)=O)=O)N7
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Quality Control

Quality Control & MSDS

View current batch:

Chemical structure

RMC-9805